Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02520024
Other study ID # 13304
Secondary ID
Status Completed
Phase N/A
First received August 1, 2015
Last updated August 10, 2015
Start date January 2010
Est. completion date March 2012

Study information

Verified date August 2015
Source Temple University Collaborative on Community Inclusion
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This project proposed to demonstrate the effectiveness, costs, and benefits to participation and community living self-directed care programming within a financially sustainable Medicaid managed care environment. The study examined outcomes associated with the implementation of a novel self-directed care (SDC) approach being implemented in Delaware County, Pennsylvania in which consumers were able to access a set amount of renewable funds per year and direct how they were spent, both to purchase the types and amounts of rehabilitation and treatment services they desire (and from whom they choose) and to purchase a broad-range of individualized resources and services that are generally outside of Medicaid funding (e.g., health club memberships, yoga classes, support in taking care of bills).


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date March 2012
Est. primary completion date March 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

1. Adults between 18-65 who are currently receiving Medicaid-reimbursed services in Delaware County, Pennsylvania for either a schizophrenia-spectrum, major depression, or bipolar disorder;

2. Individuals with a cost profile within the 60-90% band of all Magellan-administered Medicaid recipients in the county (estimated service costs between $10,048 and $22,324); 3) No more than two inpatient hospitalizations of 10 days per stay, over a 2 year period prior to the study;

4) No hospitalization within 6 months of the study; 5) Ability to understand self-directed care requirement and express interest in working with a "recovery coach."

Exclusion Criteria:

1. do not speak English;

2. have a legal guardian;

3. are unable to give informed consent

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label


Intervention

Behavioral:
self-directed care


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Temple University Collaborative on Community Inclusion

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline TU Community Participation Questionnaire to follow up at 12 months and 24 months post-baseline Used to gather information about the frequency of participation in multiple domains (e.g., employment, education, spirituality, leisure/recreation, attendance at self-help groups, etc.) in the last 30 days, whether or not they did the activity enough, not enough, or too much in addition to their level of satisfaction with their level of participation in the activity. Baseline, 12 months- and 24 months post-baseline No
Primary Change from Baseline Recovery Assessment Scale to follow up at 12 months and 24 months post-baseline Baseline, 12 months- and 24 months post-baseline No
Primary Change from Baseline Quality of Life to 12 months and 24 months post-baseline Baseline, 12 months- and 24 months post-baseline No
Primary Change from Baseline Hopkins Symptom Checklist to 12 months and 24 months post-baseline Baseline, 12 months- and 24 months post-baseline No
Primary Change from Baseline Empowerment Scale to 12 months and 24 months post-baseline Baseline, 12 months- and 24 months post-baseline No
Primary Change from Baseline Coping Mastery Questionnaire to 12 months and 24 months post-baseline Baseline, 12 months- and 24 months post-baseline No
Primary Change from Baseline Perceived Competence for Recovery Questionnaire to 12 months and 24 months post-baseline Baseline, 12 months- and 24 months post-baseline No
Primary Change from Baseline Perceived Autonomy Support: The Mental Health Questionnaire to 12 months and 24 months post-baseline Baseline, 12 months- and 24 months post-baseline No
Primary Change from Baseline Elements of a Recovery Facilitating Systems Assessment Questionnaire - Adult Version to 12 months and 24 months post-baseline Baseline, 12 months- and 24 months post-baseline No
Primary Change from Baseline Revised Camberwell Assessment of Need Questionnaire to 12 months and 24 months post-baseline Baseline, 12 months- and 24 months post-baseline No
Primary Change from Baseline Treatment Self-Regulation Questionnaire to 12 months and 24 months post-baseline Baseline, 12 months- and 24 months post-baseline No
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A